Oncology
🇺🇸 FDA Page 3FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Global oncology market intelligence for pharma BD, investors, and analysts. Track drug approvals, clinical trials, and competitive landscapes.
Showing 25–36 of 246 articles
ALX Oncology to Present at 2026 Jefferies Global Healthcare Conference, Highlighting Oncology Pipeline
Celcuity's Gedatolisib Trial Misses Expectations, Highlighting PIK3CA Inhibitor Challenges
Celcuity's Gedatolisib: Navigating the Path to Broad FDA Approval in Breast Cancer
FDA Delays Decision on AstraZeneca's Camizestrant Following Negative Adcomm Vote
Kazia Therapeutics Appoints James Levine as Chief Financial Officer
ASCO 2026 Preview: Key Data and Trends in Cancer Research
This Week in Breast Cancer: Camizestrant Delay, Bria-IMT Data, Recurrence Test
Rallybio, Avenzo agree oncology reverse merger backed by $215 million financing
FDA Oncology Draft Guidance: Reducing Animal Testing for Cancer Drugs
ASCO 2026: Key Takeaways on Cancer Care Barriers and New Treatments
ASCO 2026: Grief Takes Center Stage Amidst Cancer Data
Merck's ADC Success: Insights from Global Trial Results